To be attended by more than 200 cancer experts from across Israel and the United States, the conference will be Israel's largest scientific conference since the beginning of the Oslo War, according to the conference planners.
"There has been a long history of productive collaborations between American and Israeli scientists, resulting in significant increases in our understanding and treatment of cancer," said Hyam I. Levitsky, M.D., professor of oncology, medicine and urology at the Johns Hopkins Kimmel Cancer Center. "This conference hopefully will provide new fuel to this fire, sparking ideas, collaborations, and interest among research fellows in visiting institutions abroad."
Dr. Levitsky is a conference co-director, together with Robert Korngold, Ph.D., of The Cancer Center at Hackensack University Medical Center, and Dr. Joseph D. Rosenblatt of the University of Miami's Sylvester Comprehensive Cancer Center.
Scientists at the conference will address research advances in cancer genetics, cell signaling at the DNA/RNA level, immune system therapies, targeted treatments, novel approaches to breast cancer and tumors, and stem cell transplantation in the treatment of leukemia. A mini-symposium will address environmental causes of cancer.
Nobel laureate Avram Hershko, M.D., Ph.D., who won the 2004 Nobel Prize in chemistry, will discuss his research during a dinner address on March 16 at the Israel Museum. A member of the faculty at the Technion-Israel Institute of Technology in Haifa, Hershko was honored for his discovery of ubiquitin, a molecule that helps flag a protein to be broken down. This system is used in a variety of cell processes, including the immune system, cell division, and DNA repair. Errors in the system can lead to diseases such as cervical cancer and cystic fibrosis.
Israeli scientists made some of the first discoveries implicating the “p53” gene in cancer, now considered the most commonly mutated cancer-related gene. They also contributed to current understanding of bone marrow transplant and stem cells.
Click here for more information about the conference.
"There has been a long history of productive collaborations between American and Israeli scientists, resulting in significant increases in our understanding and treatment of cancer," said Hyam I. Levitsky, M.D., professor of oncology, medicine and urology at the Johns Hopkins Kimmel Cancer Center. "This conference hopefully will provide new fuel to this fire, sparking ideas, collaborations, and interest among research fellows in visiting institutions abroad."
Dr. Levitsky is a conference co-director, together with Robert Korngold, Ph.D., of The Cancer Center at Hackensack University Medical Center, and Dr. Joseph D. Rosenblatt of the University of Miami's Sylvester Comprehensive Cancer Center.
Scientists at the conference will address research advances in cancer genetics, cell signaling at the DNA/RNA level, immune system therapies, targeted treatments, novel approaches to breast cancer and tumors, and stem cell transplantation in the treatment of leukemia. A mini-symposium will address environmental causes of cancer.
Nobel laureate Avram Hershko, M.D., Ph.D., who won the 2004 Nobel Prize in chemistry, will discuss his research during a dinner address on March 16 at the Israel Museum. A member of the faculty at the Technion-Israel Institute of Technology in Haifa, Hershko was honored for his discovery of ubiquitin, a molecule that helps flag a protein to be broken down. This system is used in a variety of cell processes, including the immune system, cell division, and DNA repair. Errors in the system can lead to diseases such as cervical cancer and cystic fibrosis.
Israeli scientists made some of the first discoveries implicating the “p53” gene in cancer, now considered the most commonly mutated cancer-related gene. They also contributed to current understanding of bone marrow transplant and stem cells.
Click here for more information about the conference.